FDA
approval
· 2022-12-28
FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for methylphenidate hydrochloride from XLCare Pharmaceuticals, Inc., establishing a generic version of the ADHD medicati…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)